`

Monte Rosa Therapeutics

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$25.0M
size-icon Size
51 - 200

Frequently Asked Questions About Monte Rosa Therapeutics

What does Monte rosa therapeutics do?+

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosas QuEENTM (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEENTM discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industrys leading pipeline of MGDs

What is Monte rosa therapeutics's industry? +

Monte rosa therapeutics operates in the Biotechnology research industry.

What is Monte rosa therapeutics's revenue? +

Monte rosa therapeutics's revenue is 11m - 100m

What is Monte rosa therapeutics's company size? +

Monte rosa therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.